Nkx2-1: a novel tumor biomarker of lung cancer

被引:31
作者
Yang, Li [1 ,2 ]
Lin, Min [3 ]
Ruan, Wen-jing [1 ]
Dong, Liang-liang [1 ]
Chen, En-guo [1 ]
Wu, Xiao-hong [1 ]
Ying, Ke-jing [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Prov,Dept Resp Med, Hangzhou 310016, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310006, Zhejiang, Peoples R China
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Radiol, Hangzhou 310005, Zhejiang, Peoples R China
来源
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B | 2012年 / 13卷 / 11期
关键词
Nkx2-1; TTF-1; Lung cancer; Biomarker; Diagnosis; Prognosis; Therapy; TRANSCRIPTION FACTOR-I; PROTEIN-B GENE; MERKEL CELL-CARCINOMA; TTF-1; MESSENGER-RNA; SP-A GENE; THYROID TRANSCRIPTION; PRIMARY SITE; BRONCHIOLOALVEOLAR CARCINOMA; METASTATIC ADENOCARCINOMAS; CLINICAL-SIGNIFICANCE;
D O I
10.1631/jzus.B1100382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nkx2-1 (Nkx homeobox-1 gene), also known as TTF-1 (thyroid transcription factor-1), is a tissue-specific transcription factor of the thyroid, lung, and ventral forebrain. While it has been shown to play a critical role in lung development and lung cancer differentiation and morphogenesis, molecular mechanisms mediating Nkx2-1 cell- and tissue-specific expression in normal and cancerous lungs have yet to be fully elucidated. The recent identification of prognostic biomarkers in lung cancer, particularly in lung adenocarcinoma (ADC), and the different reactivity of patients to chemotherapeutic drugs have opened new avenues for evaluating patient survival and the development of novel effective therapeutic strategies. The function of Nkx2-1 as a proto-oncogene was recently characterized and the gene is implicated as a contributory factor in lung cancer development. In this review, we summarize the role of this transcription factor in the development, diagnosis, and prognosis of lung cancer in the hope of providing insights into the utility of Nkx2-1 as a novel biomarker of lung cancer.
引用
收藏
页码:855 / 866
页数:12
相关论文
共 50 条
  • [41] Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations
    Parnes, Mered
    Bashir, Hassaan
    Jankovic, Joseph
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (01): : 34 - 39
  • [42] NKX2-1 New Mutation Associated With Myoclonus, Dystonia, and Pituitary Involvement
    Balicza, Peter
    Grosz, Zoltan
    Molnar, Viktor
    Illes, Anett
    Csaban, Dora
    Gezsi, Andras
    Dezsi, Livia
    Zadori, Denes
    Vecsei, Laszlo
    Molnar, Maria Judit
    FRONTIERS IN GENETICS, 2018, 9
  • [43] NKX2-1 mutation in a family diagnosed with ataxic dyskinetic cerebral palsy
    McMichael, Gai
    Haan, Eric
    Gardner, Alison
    Yap, Tzu Ying
    Thompson, Suzanna
    Ouvrier, Robert
    Dale, Russell C.
    Gecz, Jozef
    MacLennan, Alastair H.
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2013, 56 (09) : 506 - 509
  • [44] Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer
    Wang, Zhiqiang
    Cai, Ming
    Weng, Yuan
    Zhang, Fang
    Meng, Dong
    Song, Jun
    Zhou, Huan
    Xie, Zongtao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (08) : 1353 - 1361
  • [45] Predicting the pathogenicity of NKX2-1 and IGSF1 variants with in silico bioinformatic tools
    Narumi, Satoshi
    CLINICAL PEDIATRIC ENDOCRINOLOGY, 2020, 29 (03) : 123 - 126
  • [46] A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects Only in the Presence of PAX8
    Shinohara, Hiroyuki
    Takagi, Masaki
    Ito, Kimiko
    Shimizu, Eri
    Fukuzawa, Ryuji
    Hasegawa, Tomonobu
    THYROID, 2018, 28 (08) : 1071 - 1073
  • [47] HBB as a Novel Biomarker for the Diagnosis and Monitoring of Lung Cancer Regulates Cell Proliferation via ERK1/2 Pathway
    Xu, Xinxin
    Cai, Hua
    Peng, Jingjing
    Liu, Hongli
    Chu, Fuying
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [48] Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer
    Hsu, David S.
    Acharya, Chaitanya R.
    Balakumaran, Bala S.
    Riedel, Richard F.
    Kim, Mickey K.
    Stevenson, Marvaretta
    Tuchman, Sascha
    Mukherjee, Sayan
    Barry, William
    Dressman, Holly K.
    Nevins, Joseph R.
    Powers, Scott
    Mu, David
    Potti, Anil
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) : 5312 - 5317
  • [49] Long Non-Coding RNA NANCI/NKX2-1 Duplex Impacts Prognosis in Stage I Non-Small-Cell Lung Cancer
    Moises, Jorge
    Navarro, Alfons
    Castellano, Joan Josep
    Vinolas, Nuria
    Molins, Laureano
    Canals, Jordi
    Han, Bing
    Martin, Jara
    Ramirez, Jose
    Frigola, Gerard
    Marrades, Ramon Maria
    Monzo, Mariano
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (10): : 630 - 636
  • [50] miRNA as biomarker in lung cancer
    Lobera, Esperanza Salcedo
    Varela, Macarena Arroyo
    Jimenez, Rafael Larrosa
    Moreno, Rocio Bautista
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (11) : 9521 - 9527